If a person's cell have the antigen, the antibody should NOT be present in that person's serum. If an antibody to a blood group antigen is present in the serum of a person, his or her cells should lack that antigen. The antigens are on the cells and the antibodies are in the serum.
Therapy-related myeloid leukemia (t-MDS/t-AML) is a well-recognized clinical syndrome occurring as a late complication following cytotoxic therapy.1â5 The term âtherapy-relatedâ leukemia is descriptive and based on a patientâs history of exposure to cytotoxic agents.
Acute Myeloid Leukemia (AML) Acute myeloid leukemia (AML) is a blood cancer. It happens when young abnormal white blood cells called blasts (leukemia cells), begin to fill up the bone marrow, preventing normal blood production. Doctors diagnose AML when 20 out of every 100 white blood cells in the bone marrow is a blast cell. AML is the most common acute leukemia affecting adults, with about 20,000 new cases diagnosed each year. When people have AML, blasts make copies of themselves quickly. This slows the production of red blood cells and platelets, causing tiredness from anemia and a risk of bleeding from a low platelet count.